Revision sistematica y metaanalisis de inhibidores de interleucina-6 para reducir la mortalidad en pacientes hospitalizados con COVID, Systematic review and meta-analysis of interleulin-6 inhibitors in reducing mortality for hospitalized patients with COVID-19

Alegre-Del-Rey, E. J.; Fenix-Caballero, S.; Salmeron-Navas, F. J.; Gil-Sierra, M. D.; Sierra-Sanchez, J. F.; Diaz-Alersi Rosety, R. L.

Alegre-Del-Rey, E. J.; Fenix-Caballero, S.; Salmeron-Navas, F. J.; Gil-Sierra, M. D.; Sierra-Sanchez, J. F.; Diaz-Alersi Rosety, R. L..

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria ; 46(3):166-172, 2022.

Article in English | EMBASE | ID: covidwho-2057459

Keywords

adult; article; coronavirus disease 2019; drug therapy; Embase; female; hospital patient; human; male; Medline; meta analysis; mortality; mortality risk; patent; randomized controlled trial (topic); sensitivity analysis; software; systematic review; endogenous compound; interleukin 6; sarilumab; steroid; tocilizumab

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Type of study: Reviews / Systematic review/Meta Analysis Language: English Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML